Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Non-cash Items (2020 - 2025)

AVITA Medical's Non-cash Items history spans 6 years, with the latest figure at $5.1 million for Q4 2025.

  • For Q4 2025, Non-cash Items fell 32.89% year-over-year to $5.1 million; the TTM value through Dec 2025 reached $5.1 million, down 32.89%, while the annual FY2025 figure was $5.1 million, 32.89% down from the prior year.
  • Non-cash Items reached $5.1 million in Q4 2025 per RCEL's latest filing, down from $7.6 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $12.2 million in Q2 2021 to a low of $1.5 million in Q4 2022.
  • Average Non-cash Items over 5 years is $5.5 million, with a median of $5.1 million recorded in 2021.
  • Peak YoY movement for Non-cash Items: plummeted 70.1% in 2022, then soared 396.65% in 2024.
  • A 5-year view of Non-cash Items shows it stood at $5.1 million in 2021, then tumbled by 70.1% to $1.5 million in 2022, then changed by 0.0% to $1.5 million in 2023, then skyrocketed by 396.65% to $7.6 million in 2024, then plummeted by 32.89% to $5.1 million in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Non-cash Items are $5.1 million (Q4 2025), $7.6 million (Q4 2024), and $1.5 million (Q4 2023).